Daré Bioscience (DARE) Short Interest Ratio & Short Volume $2.97 +0.04 (+1.37%) Closing price 03:58 PM EasternExtended Trading$2.97 0.00 (0.00%) As of 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Daré Bioscience Short Interest DataDaré Bioscience (DARE) has a short interest of 47,400 shares, representing 0.54% of the float (the number of shares available for trading by the public). This marks a -24.04% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 39,196 shares to cover all short positions.Current Short Interest47,400 sharesPrevious Short Interest62,400 sharesChange Vs. Previous Month-24.04%Dollar Volume Sold Short$139,830.00Short Interest Ratio2.1 Days to CoverLast Record DateApril 15, 2025Outstanding Shares8,850,000 sharesFloat Size8,710,000 sharesShort Percent of Float0.54%Today's Trading Volume4,108 sharesAverage Trading Volume39,196 sharesToday's Volume Vs. Average10% Short Selling Daré Bioscience? Sign up to receive the latest short interest report for Daré Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDARE Short Interest Over TimeDARE Days to Cover Over TimeDARE Percentage of Float Shorted Over Time Daré Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202547,400 shares $139,830.00 -24.0%0.5%2.1 $2.95 3/31/202562,400 shares $180,336.00 -28.6%0.7%2.6 $2.89 3/15/202587,400 shares $251,712.00 +22.2%1.0%3.1 $2.88 2/28/202571,500 shares $224,510.00 -21.5%0.8%2 $3.14 2/15/202591,100 shares $276,944.00 +4.0%1.1%2.4 $3.04 1/31/202587,600 shares $284,700.00 -4.3%1.0%2 $3.25 1/15/202591,500 shares $304,695.00 +5.7%1.1%1.9 $3.33 12/31/202486,600 shares $270,192.00 +50.9%1.0%1.7 $3.12 12/15/202457,400 shares $182,532.00 +2.9%0.7%1.1 $3.18 11/30/202455,800 shares $190,836.00 +118.8%0.7%1.4 $3.42 Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 11/15/202425,500 shares $81,855.00 -13.3%0.3%0.6 $3.21 10/31/202429,400 shares $124,362.00 -33.9%0.4%0.7 $4.23 10/15/202444,500 shares $156,195.00 +14.7%0.5%1.2 $3.51 9/30/202438,800 shares $125,712.00 +9.6%0.5%1 $3.24 9/15/202435,400 shares $117,174.00 -9.7%0.4%0.8 $3.31 8/31/202439,200 shares $140,336.00 +19.9%0.5%0.8 $3.58 8/15/202432,700 shares $113,796.00 +51.4%0.4%0.7 $3.48 7/31/202421,600 shares $74,088.00 -63.3%0.3%0.5 $3.43 7/15/202458,900 shares $198,493.00 +68.3%0.7%0.9 $3.37 6/30/202435,000 shares $141,162.00 -79.8%0.4%0.5 $4.03 6/15/2024172,900 shares $77,770.42 -71.2%N/A0.3 $0.45 5/31/2024600,200 shares $246,082.00 +12.6%N/A0.9 $0.41 5/15/2024532,900 shares $191,844.00 +83.6%N/A0.7 $0.36 4/30/2024290,300 shares $89,267.25 +17.6%N/A0.4 $0.31 4/15/2024246,900 shares $118,536.69 +5.1%N/A0.6 $0.48 3/31/2024235,000 shares $115,197.00 -48.5%N/A0.6 $0.49 3/15/2024456,200 shares $213,684.08 -14.0%N/A1.1 $0.47 2/29/2024530,500 shares $304,507.00 +5.2%N/A0.8 $0.57 2/15/2024504,200 shares $184,385.94 -10.1%N/A0.8 $0.37 1/31/2024560,900 shares $182,292.50 -11.3%N/A1 $0.33 1/15/2024632,000 shares $229,795.20 -27.3%N/A1.1 $0.36 12/31/2023869,800 shares $268,768.20 -11.2%N/A1.6 $0.31 12/15/2023979,200 shares $344,580.48 +76.8%N/A2 $0.35 11/30/2023553,900 shares $193,865.00 +23.9%N/A1.3 $0.35 11/15/2023447,000 shares $152,963.40 -22.6%N/A1.8 $0.34 10/31/2023577,300 shares $247,084.40 +0.9%N/A2.5 $0.43 10/15/2023572,300 shares $263,258.00 -4.7%N/A2.4 $0.46 9/30/2023600,300 shares $277,218.54 +4.8%N/A2.2 $0.46 9/15/2023572,800 shares $292,128.00 -31.6%N/A1.9 $0.51 8/31/2023836,800 shares $572,622.24 +19.4%N/A2.7 $0.68Trump Orders 'National Digital Asset Stockpile' (Ad)Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu 8/15/2023700,900 shares $515,091.41 +11.6%N/A2.4 $0.73 7/31/2023628,300 shares $469,151.61 -9.3%N/A2.2 $0.75 7/15/2023692,400 shares $602,388.00 +45.1%N/A2.6 $0.87 6/30/2023477,100 shares $434,208.71 +29.4%N/A2.2 $0.91 6/15/2023368,600 shares $353,856.00 +7.6%N/A1.9 $0.96 5/31/2023342,600 shares $346,026.00 -9.5%N/A1.8 $1.01 5/15/2023378,600 shares $382,386.00 -25.9%N/A2 $1.01 4/30/2023511,000 shares $511,000.00 -16.6%N/A2.5 $1.00 4/15/2023612,400 shares $618,524.00 +12.5%N/A2.2 $1.01 3/31/2023544,400 shares $566,176.00 +16.8%N/A1.8 $1.04 3/15/2023466,000 shares $466,000.00 -15.9%N/A1.5 $1.00 2/28/2023554,100 shares $576,264.00 -49.6%N/A1.8 $1.04 2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13 1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27 1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20 12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83 12/15/20221,020,000 shares $922,080.00 -12.8%N/A4.1 $0.90 11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89 11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95 10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97 10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89 9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00 9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10 8/31/20221,460,000 shares $1.58 million -2.7%N/A2 $1.08 8/15/20221,500,000 shares $1.89 million +2.7%N/A1.8 $1.26 7/31/20221,460,000 shares $1.62 million -0.7%N/A1.6 $1.11 7/15/20221,470,000 shares $1.81 million -24.6%N/A1.4 $1.23 6/30/20221,950,000 shares $2.40 million +18.9%N/A1.7 $1.23 6/15/20221,640,000 shares $2.00 million -15.9%N/A1.2 $1.22 5/31/20221,950,000 shares $2.40 million -14.5%N/A1.4 $1.23 5/15/20222,280,000 shares $2.39 million -1.7%N/A1.6 $1.05 4/30/20222,320,000 shares $2.62 million +10.0%N/A1.5 $1.13 4/15/20222,110,000 shares $2.89 million +1.0%N/A1.2 $1.37 3/31/20222,090,000 shares $3.11 million -2.8%N/A1 $1.49 3/15/20222,150,000 shares $3.14 million -8.9%N/A0.9 $1.46 2/28/20222,360,000 shares $3.52 million +7.8%N/A0.4 $1.49 2/15/20222,190,000 shares $3.48 million -17.7%N/A0.4 $1.59 1/31/20222,660,000 shares $4.18 million -22.7%N/A0.5 $1.57 1/15/20223,440,000 shares $5.71 million -6.0%N/A0 $1.66 12/31/20213,660,000 shares $7.32 million -39.6%N/A0.7 $2.00 12/15/20216,060,000 shares $11.15 million +227.6%N/A1.1 $1.84 11/30/20211,850,000 shares $3.33 million +4.5%N/A0.4 $1.80 11/15/20211,770,000 shares $3.06 million -22.4%N/A0.8 $1.73 10/29/20212,280,000 shares $3.33 million +72.7%N/A0.8 $1.46 10/15/20211,320,000 shares $2.07 million -20.5%N/A0.4 $1.57 9/30/20211,660,000 shares $2.77 million -48.0%N/A0.4 $1.67 9/15/20213,190,000 shares $5.33 million -31.3%N/A0.3 $1.67 8/31/20214,640,000 shares $8.12 million -3.1%N/A0.5 $1.75 8/13/20214,790,000 shares $7.66 million +8.9%N/A0.5 $1.60 7/30/20214,400,000 shares $6.78 million -16.2%9.5%0.5 $1.54Trump Orders 'National Digital Asset Stockpile' (Ad)Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu 7/15/20215,250,000 shares $8.45 million +126.3%11.4%0.7 $1.61 6/30/20212,320,000 shares $4.38 million +82.7%5.0%0.3 $1.89 6/15/20211,270,000 shares $1.70 million -0.8%2.8%1.6 $1.34 5/28/20211,280,000 shares $1.64 million -1.5%2.8%1.6 $1.28 5/14/20211,300,000 shares $1.61 million +12.1%N/A1.4 $1.24 4/30/20211,160,000 shares $1.75 million +0.9%N/A1 $1.51 4/15/20211,150,000 shares $1.73 million -6.5%N/A0 $1.50 3/31/20211,230,000 shares $2.03 million +1.7%N/A0.4 $1.65 3/15/20211,210,000 shares $2.69 million +0.8%N/A0.4 $2.22 2/26/20211,200,000 shares $2.32 million -16.1%N/A0.4 $1.93 2/12/20211,430,000 shares $3.42 million +10.9%N/A0.5 $2.39 1/29/20211,290,000 shares $2.79 million +126.5%N/A0.4 $2.16 1/15/2021569,500 shares $877,030.00 -22.9%N/A0.2 $1.54 12/31/2020738,400 shares $967,304.00 +41.3%N/A0.7 $1.31 12/15/2020522,600 shares $600,990.00 +51.1%N/A0.5 $1.15 11/30/2020345,900 shares $466,965.00 +44.8%N/A0.4 $1.35 11/15/2020238,900 shares $258,012.00 -4.6%N/A0.4 $1.08 10/30/2020250,400 shares $245,392.00 +296.8%N/A0.5 $0.98 10/15/202063,100 shares $67,517.00 -45.2%N/A0.1 $1.07 9/30/2020115,200 shares $115,050.24 -38.3%N/A0.1 $1.00 9/15/2020186,600 shares $207,126.00 +15.3%N/A0.2 $1.11 8/31/2020161,900 shares $174,852.00 -20.8%N/A0.2 $1.08 8/14/2020204,500 shares $233,130.00 -50.2%N/A0.2 $1.14 7/31/2020410,400 shares $455,544.00 +58.6%N/A0.5 $1.11 7/15/2020258,800 shares $326,088.00 -1.6%N/A0.3 $1.26 6/30/2020263,100 shares $260,100.66 +52.6%N/A0.7 $0.99 6/15/2020172,400 shares $170,762.20 -13.9%N/A0.5 $0.99 5/29/2020200,300 shares $208,312.00 -16.5%N/A0.6 $1.04 5/15/2020239,900 shares $244,698.00 -35.4%N/A0.6 $1.02 DARE Short Interest - Frequently Asked Questions What is Daré Bioscience's current short interest? Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 47,400 shares of DARE short. 0.54% of Daré Bioscience's shares are currently sold short. Learn More on Daré Bioscience's current short interest. What is a good short interest ratio for Daré Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DARE shares currently have a short interest ratio of 2.0. Learn More on Daré Bioscience's short interest ratio. Which institutional investors are shorting Daré Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Daré Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Daré Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.54% of Daré Bioscience's floating shares are currently sold short. Is Daré Bioscience's short interest increasing or decreasing? Daré Bioscience saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 47,400 shares, a decline of 24.0% from the previous total of 62,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Daré Bioscience's float size? Daré Bioscience currently has issued a total of 8,850,000 shares. Some of Daré Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Daré Bioscience currently has a public float of 8,710,000 shares. How does Daré Bioscience's short interest compare to its competitors? 0.54% of Daré Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Daré Bioscience: Instil Bio, Inc. (16.45%), Senti Biosciences, Inc. (0.88%), RAPT Therapeutics, Inc. (12.25%), C4 Therapeutics, Inc. (11.97%), Zentalis Pharmaceuticals, Inc. (7.67%), Alector, Inc. (7.45%), Tonix Pharmaceuticals Holding Corp. (16.28%), Silence Therapeutics plc (5.41%), Coya Therapeutics, Inc. (2.16%), Immunic, Inc. (2.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Daré Bioscience stock? Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. DARE shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Daré Bioscience? A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further. How often is Daré Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies TIL Short Squeeze SNTI Short Squeeze RAPT Short Squeeze CCCC Short Squeeze ZNTL Short Squeeze ALEC Short Squeeze TNXP Short Squeeze SLN Short Squeeze COYA Short Squeeze IMUX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DARE) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.